Co-Injection of Sulfotyrosine Facilitates Retinal Uptake of Hyaluronic Acid Nanospheres Following Intravitreal Injection

Gene and drug delivery to the retina is a critical therapeutic goal. While the majority of inherited forms of retinal degeneration affect the outer retina, specifically the photoreceptors and retinal pigment epithelium, effective targeted delivery to this region requires invasive subretinal delivery...

Full description

Bibliographic Details
Main Authors: Aiden Eblimit, Mustafa S. Makia, Daniel Strayve, Ryan Crane, Shannon M. Conley, Tirthankar Sinha, Ghanashyam Acharya, Muayyad R. Al-Ubaidi, Muna I. Naash
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/9/1510
_version_ 1797517540573839360
author Aiden Eblimit
Mustafa S. Makia
Daniel Strayve
Ryan Crane
Shannon M. Conley
Tirthankar Sinha
Ghanashyam Acharya
Muayyad R. Al-Ubaidi
Muna I. Naash
author_facet Aiden Eblimit
Mustafa S. Makia
Daniel Strayve
Ryan Crane
Shannon M. Conley
Tirthankar Sinha
Ghanashyam Acharya
Muayyad R. Al-Ubaidi
Muna I. Naash
author_sort Aiden Eblimit
collection DOAJ
description Gene and drug delivery to the retina is a critical therapeutic goal. While the majority of inherited forms of retinal degeneration affect the outer retina, specifically the photoreceptors and retinal pigment epithelium, effective targeted delivery to this region requires invasive subretinal delivery. Our goal in this work was to evaluate two innovative approaches for increasing both the persistence of delivered nanospheres and their penetration into the outer retina while using the much less invasive intravitreal delivery method. We formulated novel hyaluronic acid nanospheres (HA-NS, 250 nm and 500 nm in diameter) conjugated to fluorescent reporters and delivered them intravitreally to the adult Balb/C mouse retina. They exhibited persistence in the vitreous and along the inner limiting membrane (ILM) for up to 30 days (longest timepoint examined) but little retinal penetration. We thus evaluated the ability of the small molecule, sulfotyrosine, to disrupt the ILM, and found that 3.2 µg/µL sulfotyrosine led to significant improvement in delivery to the outer retina following intravitreal injections without causing retinal inflammation, degeneration, or loss of function. Co-delivery of sulfotyrosine and HA-NS led to robust improvements in penetration of HA-NS into the retina and accumulation along the interface between the photoreceptors and the retinal pigment epithelium. These exciting findings suggest that sulfotyrosine and HA-NS may be an effective strategy for outer retinal targeting after intravitreal injection.
first_indexed 2024-03-10T07:17:57Z
format Article
id doaj.art-0a139b58594443809308ff063f0c6002
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T07:17:57Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-0a139b58594443809308ff063f0c60022023-11-22T14:48:50ZengMDPI AGPharmaceutics1999-49232021-09-01139151010.3390/pharmaceutics13091510Co-Injection of Sulfotyrosine Facilitates Retinal Uptake of Hyaluronic Acid Nanospheres Following Intravitreal InjectionAiden Eblimit0Mustafa S. Makia1Daniel Strayve2Ryan Crane3Shannon M. Conley4Tirthankar Sinha5Ghanashyam Acharya6Muayyad R. Al-Ubaidi7Muna I. Naash8Department of Biomedical Engineering, College of Engineering, University of Houston, 3517 Cullen Blvd, SERC 2009, Houston, TX 77204, USADepartment of Biomedical Engineering, College of Engineering, University of Houston, 3517 Cullen Blvd, SERC 2009, Houston, TX 77204, USADepartment of Biomedical Engineering, College of Engineering, University of Houston, 3517 Cullen Blvd, SERC 2009, Houston, TX 77204, USADepartment of Biomedical Engineering, College of Engineering, University of Houston, 3517 Cullen Blvd, SERC 2009, Houston, TX 77204, USADepartment of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USADepartment of Biomedical Engineering, College of Engineering, University of Houston, 3517 Cullen Blvd, SERC 2009, Houston, TX 77204, USADepartment of Surgery, Baylor College of Medicine, Houston, TX 77030, USADepartment of Biomedical Engineering, College of Engineering, University of Houston, 3517 Cullen Blvd, SERC 2009, Houston, TX 77204, USADepartment of Biomedical Engineering, College of Engineering, University of Houston, 3517 Cullen Blvd, SERC 2009, Houston, TX 77204, USAGene and drug delivery to the retina is a critical therapeutic goal. While the majority of inherited forms of retinal degeneration affect the outer retina, specifically the photoreceptors and retinal pigment epithelium, effective targeted delivery to this region requires invasive subretinal delivery. Our goal in this work was to evaluate two innovative approaches for increasing both the persistence of delivered nanospheres and their penetration into the outer retina while using the much less invasive intravitreal delivery method. We formulated novel hyaluronic acid nanospheres (HA-NS, 250 nm and 500 nm in diameter) conjugated to fluorescent reporters and delivered them intravitreally to the adult Balb/C mouse retina. They exhibited persistence in the vitreous and along the inner limiting membrane (ILM) for up to 30 days (longest timepoint examined) but little retinal penetration. We thus evaluated the ability of the small molecule, sulfotyrosine, to disrupt the ILM, and found that 3.2 µg/µL sulfotyrosine led to significant improvement in delivery to the outer retina following intravitreal injections without causing retinal inflammation, degeneration, or loss of function. Co-delivery of sulfotyrosine and HA-NS led to robust improvements in penetration of HA-NS into the retina and accumulation along the interface between the photoreceptors and the retinal pigment epithelium. These exciting findings suggest that sulfotyrosine and HA-NS may be an effective strategy for outer retinal targeting after intravitreal injection.https://www.mdpi.com/1999-4923/13/9/1510hyaluronic acid nanospheresretinaphotoreceptorRPEintravitreal injectionsulfotyrosine
spellingShingle Aiden Eblimit
Mustafa S. Makia
Daniel Strayve
Ryan Crane
Shannon M. Conley
Tirthankar Sinha
Ghanashyam Acharya
Muayyad R. Al-Ubaidi
Muna I. Naash
Co-Injection of Sulfotyrosine Facilitates Retinal Uptake of Hyaluronic Acid Nanospheres Following Intravitreal Injection
Pharmaceutics
hyaluronic acid nanospheres
retina
photoreceptor
RPE
intravitreal injection
sulfotyrosine
title Co-Injection of Sulfotyrosine Facilitates Retinal Uptake of Hyaluronic Acid Nanospheres Following Intravitreal Injection
title_full Co-Injection of Sulfotyrosine Facilitates Retinal Uptake of Hyaluronic Acid Nanospheres Following Intravitreal Injection
title_fullStr Co-Injection of Sulfotyrosine Facilitates Retinal Uptake of Hyaluronic Acid Nanospheres Following Intravitreal Injection
title_full_unstemmed Co-Injection of Sulfotyrosine Facilitates Retinal Uptake of Hyaluronic Acid Nanospheres Following Intravitreal Injection
title_short Co-Injection of Sulfotyrosine Facilitates Retinal Uptake of Hyaluronic Acid Nanospheres Following Intravitreal Injection
title_sort co injection of sulfotyrosine facilitates retinal uptake of hyaluronic acid nanospheres following intravitreal injection
topic hyaluronic acid nanospheres
retina
photoreceptor
RPE
intravitreal injection
sulfotyrosine
url https://www.mdpi.com/1999-4923/13/9/1510
work_keys_str_mv AT aideneblimit coinjectionofsulfotyrosinefacilitatesretinaluptakeofhyaluronicacidnanospheresfollowingintravitrealinjection
AT mustafasmakia coinjectionofsulfotyrosinefacilitatesretinaluptakeofhyaluronicacidnanospheresfollowingintravitrealinjection
AT danielstrayve coinjectionofsulfotyrosinefacilitatesretinaluptakeofhyaluronicacidnanospheresfollowingintravitrealinjection
AT ryancrane coinjectionofsulfotyrosinefacilitatesretinaluptakeofhyaluronicacidnanospheresfollowingintravitrealinjection
AT shannonmconley coinjectionofsulfotyrosinefacilitatesretinaluptakeofhyaluronicacidnanospheresfollowingintravitrealinjection
AT tirthankarsinha coinjectionofsulfotyrosinefacilitatesretinaluptakeofhyaluronicacidnanospheresfollowingintravitrealinjection
AT ghanashyamacharya coinjectionofsulfotyrosinefacilitatesretinaluptakeofhyaluronicacidnanospheresfollowingintravitrealinjection
AT muayyadralubaidi coinjectionofsulfotyrosinefacilitatesretinaluptakeofhyaluronicacidnanospheresfollowingintravitrealinjection
AT munainaash coinjectionofsulfotyrosinefacilitatesretinaluptakeofhyaluronicacidnanospheresfollowingintravitrealinjection